Search

Your search keyword '"Lindeman, GJ"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Lindeman, GJ" Remove constraint Author: "Lindeman, GJ"
285 results on '"Lindeman, GJ"'

Search Results

1. Spotlight on the utility of the Oncotype DX® breast cancer assay

2. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care

3. Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells

4. Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer

5. Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells

6. VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results

7. R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue

8. In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis

9. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast

10. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors

12. Single cell transcriptome atlas of mouse mammary epithelial cells across development

13. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

14. Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis

15. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast

21. Mammography Adherence among High-Risk Women with Breast Cancer and Either a Non-Pathogenic Mutation Identified or Untested BRCA1/2 Genetic Status

22. Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience

23. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis

24. Targeting triple-negative breast cancers with the Smac-mimetic birinapant

25. Preferences for breast cancer prevention among women with aBRCA1orBRCA2mutation

26. Abstract PD1-06: A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2–positive metastatic breast cancer (MBC)

28. Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer (vol 10, 766, 2019)

29. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

30. Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer

31. Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

32. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

33. Spotlight on the utility of the Oncotype DX® breast cancer assay

34. Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids

35. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018)

36. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

37. Abstract S2-04: RANK ligand as a target for breast cancer prevention in BRCA1 mutation carriers

38. Construction of developmental lineage relationships in the mouse mammary gland by single-cell RNA profiling

39. Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment

40. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells

41. Essential role for a novel population of binucleated mammary epithelial cells in lactation

42. The complexities and caveats of lineage tracing in the mammary gland

43. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

44. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

45. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits

46. A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1

47. Patient-derived xenograft models of breast cancer and their predictive power

48. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine

49. Tumour morphology predicts PALB2 germline mutation status

50. Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first-or second-line treatment of patients with metastatic triple-negative breast cancer

Catalog

Books, media, physical & digital resources